Vivani Medical, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VANI | MNOV | RNA | VTVT | OBIO | SPL.AX | |
|---|---|---|---|---|---|---|
| Market cap | 96.52M | 71.37M | 148.48M | 95.01M | 360.63M | 222.14M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -3.1 | -2.8 | -1.5 | -5.5 | -4.0 | 102.2 |
| Price/book | 5.0 | 1.9 | 0.7 | 3.8 | 18.7 | 13.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −27.21% | +3.57% | −41.15% | −5.65% | +57.48% | +37.88% |
| Today | +1.90% | +2.11% | −0.46% | +2.04% | +7.91% | +1.10% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All VANI news ›/C O R R E C T I O N - Vivalink/
Oct 22, 2026, 09:39 ET In the news release, Vivalink Powers Translational Medicine Through Continuous Physiologic Monitoring Across Healthcare and Clinical Research, issued Oct. 22, 2026 by Vivalink over PR Newswire, we are advised by a…
Minor update (10) for Vivaldi Desktop 8.2
This update includes a minor upgrade to Chromium 152 (Extended Stable Release) from upstream, which in turn includes security fixes from Chromium 155. By Ruarí ØdegaardOctober 14, 2026377 views The following improvements were made since…
Vivani Medical Announces Participation in Upcoming Investor Conferences
ALAMEDA, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra-long-acting drug implants utilizing its proprietary…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- globenewswire.com1
- manilatimes.net1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.